CELL Technologies
CompanyCanada
CELL Technologies develops one asset, in phase 3 (Autologous Bone Marrow Aspirate Concentrate in knee osteoarthritis). Mostly cell therapy; based in Canada.
- 1
- Asset
- Furthest stage
- Phase 3
- 1
- Trial
- 1
- Signal
Pipeline
1Autologous Bone Marrow Aspirate Concentrate
Autologous concentrated bone marrow cells delivering progenitor cells and anti-inflammatory factors for cartilage repair
Phase 3, Cell therapy, knee osteoarthritis, musculoskeletal disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals1
- Integrity notices2
- Similar companies6